Your browser doesn't support javascript.
loading
Japanese physicians' perceptions of conflicts of interest with pharmaceutical companies: Estimating two different questioning approaches.
Saito, Hiroaki; Ozaki, Akihiko; Murakami, Michio; Takebayashi, Yoshitake.
Afiliación
  • Saito H; Department of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan.
  • Ozaki A; Department of Internal Medicine, Soma Central Hospital, Soma, Fukushima, Japan.
  • Murakami M; Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
  • Takebayashi Y; Department of Health Risk Communication, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan.
Int J Health Plann Manage ; 39(2): 541-555, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38172086
ABSTRACT
Despite being one of the world's largest pharmaceutical markets, interactions between Japanese physicians and pharmaceutical companies often remain opaque. Importantly, potential conflicts of interest associated with these interactions can compromise patient care and increase costs. We conducted an online survey of Japanese physicians to elucidate perspectives on pharmaceutical company promotional activities and how these influence physician prescribing patterns. Anticipating that physicians might downplay their reliance on, or the value of, pharmaceutical company-provided information, the survey incorporated a direct questioning method and an unmatched count technique (UCT) to identify hidden perceptions on factors likely to influence prescribing. Overall, 1080 eligible physicians participated. Of these, 105 (9.7%) self-identified as hospital directors or managers. Surprisingly, nearly twice as many participants responding to direct questioning (18.9%) versus those responding to the UCT (10.1%) asserted that information provided by pharmaceutical companies was important when prescribing medicine. Hospital directors or managers (adjusted odds ratio [adjOR] 2.56, 95% confidence interval [95% CI] 1.00-6.54, reference = physician without title) and frequent interactions with pharmaceutical sales representatives (adjOR 5.96, 95% CI 1.88-18.9, reference = rare interaction) significantly valued the information from sales representatives and sponsored lectures when considering prescribing decisions. Additionally, 77.1% of respondents believed that sales representatives provide fair, neutral, or relatively honest and unbiased information about their products. Few Japanese physicians acknowledged the influence of industry-provided information on prescribing patterns. Our study uniquely applies two distinct question formats, providing a novel approach to understanding the depth of physician-industry relationships and the effectiveness of various survey methodologies.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médicos / Conflicto de Intereses Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Health Plann Manage Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE / SERVICOS DE SAUDE Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médicos / Conflicto de Intereses Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Health Plann Manage Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE / SERVICOS DE SAUDE Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido